Abstract
The authors treated a 6-month-old boy with malignant infantile osteopetrosis using bone marrow transplantation. The patient's clinical response was compared with his biochemical response for bone metabolic markers such as tartrate-resistant acid phosphatase 5b (TRAcP 5b) and bone-specific alkaline phosphatase (BAP). Treatment was successful, resulting in a decrease in the serum TRAcP 5b level. These bone-specific markers may be useful for the early assessment of malignant infantile osteopetrosis patients with stem cell transplantation.
| Original language | English |
|---|---|
| Pages (from-to) | 5-8 |
| Number of pages | 4 |
| Journal | Journal of Pediatric Hematology/Oncology |
| Volume | 26 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2004 |
| Externally published | Yes |
Keywords
- Bone marrow transplantation
- Bone-specific alkaline phosphatase
- Children
- Malignant infantile osteopetrosis
- Tartrate-resistant acid phosphatase 5b
ASJC Scopus subject areas
- Hematology
- Oncology
- Pediatrics, Perinatology, and Child Health
Fingerprint
Dive into the research topics of 'Osteoblast and Osteoclast Activity in a Malignant Infantile Osteopetrosis Patient Following Bone Marrow Transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS